Researchers at CERN have just upgraded their understanding on one of the rarest particle ...

Aisa Pharma, Inc., a clinical-stage biopharmaceutical company focused on therapies for systemic sclerosis, today announced results from its Phase 2 RECONNOITER trial of AISA-021 (cilnidipine), a novel ...

Superagers’ memory capacity rivals that of younger adults. A new study suggests their brains’ robust production of new neurons may be why.

Gabriel Magalhaes and Bukayo Saka have dismissed time-wasting claims from Brighton boss Fabian Hurzeler after Arsenal moved ...

In hormone receptor (HR)–positive, HER2-negative advanced breast cancer, starting CDK4/6 inhibitors (CDK4/6i) in the first line of therapy did not improve overall survival (OS) compared with reserving ...

The FDA is expected to decide on treatments for Alzheimer disease agitation, focal segmental glomerulosclerosis, hematological malignancies, HIV-1, and obesity.

The study of the one-in-ten-billion kaon decay allows researchers to stress-test the Standard Model of particle physics.

Nearly 70% of patients with mild-to-moderate Crohn’s disease following a 5-day-per-month fasting-mimicking diet achieve a clinical response in a controlled trial.

Invivyd, Inc. (NASDAQ:IVVD) Q4 2025 Earnings Call Transcript March 5, 2026 Invivyd, Inc. misses on earnings expectations. Reported EPS is $-0.06428 EPS, expectations were $-0.06. Operator: Good day, ...

Despite just turning 17 last March, a shy, soft-spoken kid from Panama, who tips the scales at 107 pounds, carried the weight of being labeled worthy of an Eclipse Award from the very start. When ...

Is the world getting hotter, faster? It’s a big question which has been puzzling and dividing scientists for years. A new paper says it has the answer, and it’s not good news.

Background Japanese guidelines recommend a corticosteroid maintenance dose of 5–10 mg/day for cardiac sarcoidosis (CS); however, the optimal dose remains unclear. This study aimed to evaluate the ...